Cargando…
5.M. Workshop: The need to account for vaccine-specificities in the implementation of the EU Regulation on HTA
: In January 2022, the EU Regulation on Health Technology Assessment (HTAR) entered into force. The HTAR provides for the centralized conduct of EU-wide joint clinical assessment (JCA) for oncology treatments (2025 onwards), and for other medicinal products incl. vaccines (2030 onwards). HTA is a m...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620040/ http://dx.doi.org/10.1093/eurpub/ckac129.326 |
Ejemplares similares
-
The development of HTA collaboration at European level and the challenge of the EU regulation
por: Ruether, A, et al.
Publicado: (2022) -
3.G. Round table: European Union policies: the basis for EU legislation and the case of the EU HTA regulation
Publicado: (2023) -
2.G. Workshop: The development of HTA collaboration in Europe: where we are and where we are going
Publicado: (2022) -
HTA and National Immunisation Program: an overview of competent bodies and of the impact of HTA on the decision-making process
por: Ricciardi, W
Publicado: (2022) -
6.M. Workshop: Models of care in prison: addressing infectious diseases during and after the pandemic in EU/EEA
Publicado: (2022)